Skip to main content

New and competing renewal awards for March 2019 to September 2019

Wednesday, October 23, 2019
McGovern Davison Children's Health Center

The following are new and competing renewal awards made to faculty in the Department of Pediatrics for the months of October through December 2018. Congratulations to these faculty on their awards and best wishes to them in their investigative work.

March 2019

Charles M. Cotton (Neonatology) received an award from Baebies, Inc. in the amount of $42,339 for a research project entitled “Near Patient Acute Kidney Injury Biomarker Analysis in Critically Ill Neonates - Phase II.” The project period is 12/01/2018 – 11/30/2019.

Genevieve G. Fouda (Infectious Diseases) received an award from National Institutes of Health in the amount of $3,638,480 for a research study entitled “Neutralizing and Non-Neutralizing Anti-Body Effector Functions in HIV Infected Children.” The project period is 04/01/2019 – 03/31/2024.

Benjamin A. Goldstein (Biostatistics and Bioinformatics) and Jason E. Lang (Pulmonary and Sleep Medicine) received an award from National Heart, Lung and Blood Institute in the amount of $120,500 for a research study entitled “Multifactorial Spatiotemporal Analyses to Evaluate Environmental Triggers and Patient-Level Clinical Characteristics of Severe Asthma Exacerbations in Children.” The project period is 03/04/2019 – 02/28/2021.

Jennifer S. Li (Cardiology) received an award from Colin’s Kids, Inc. in the amount of $100,000 for a research project entitled “The Colin's Kids Pediatric Cardiology Research.” The project period is 01/01/2019 – 12/31/2023. 

Michael Anthony Moody (Infectious Diseases) received an award from Fred Hutchinson Cancer Research Center in the amount of $257,526 for a research study entitled “HVTN Phase I Protocol Funding 2.” The project period is 12/01/2018 – 11/30/2020.

Eliana M. Perrin (Primary Care) received a sub-award from University of North Carolina at Chapel Hill in the amount of $70,402 for a research study entitled “Healthy Mothers Healthy Children.” The project period is 08/30/2018 – 06/30/2023. 

John W. Sleasman (Allergy and Immunology) received an award from Baxalta US Inc. in the amount of $141,932 for a research study entitled “Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric Subjects with Primary Immunodeficiency Diseases.” The project period is 10/01/2018 – 04/30/2020.

Michael J. Smith (Infectious Diseases) received an award from Tetraphase Pharmaceuticals Inc. in the amount of $52,772 for a research study entitled “A Phase I, Open Label, Multicenter Study to Determine the Pharmacokinetics and Safety of Intravenous Eravacycline in Children with Suspected or Confirmed Bacterial Infection.” The project period is 03/08/2019 – 03/14/2020.

Sarah P. Young (Medical Genetics) received an award from Inventiva Pharma in the amount of $20,000 for a research study entitled “Analysis of Glycosaminoglycans in Mucopolysaccharidosis Type-VI.” The project period is 03/06/2019 – 03/05/2020.

April 2019

Sarah C. Armstrong (Primary Care) received an award from FirstHealth of the Carolinas in the amount of $37,744 for a research study entitled “Active Recreation Through Community-Healthcare Engagements (ARCHES).” The project period is 07/01/2018 – 06/30/2019.

Genevieve G. Fouda (Infectious Diseases) received an award from National Institutes of Health in the amount of $1,570,691 for a research study entitled “Supramolecular Pediatric NIV Vaccine Design.” The project period is 04/01/2019 – 03/31/2021.

Gabriela M. Maradiaga Panayotti (Primary Care) received an award from American Academy of Pediatrics in the amount of $2,000 for a training project entitled “Practical Strategies to Improve Breastfeeding Promotion and Support in Your Busy Practice.” The project period is 05/01/2019 – 04/30/2020.

Kristin M. Page (Blood and Marrow Transplantation) received an award from Incyte Corporation in the amount of $234,463 for a research study entitled “An Open-Label, Single-Arm Phase ½ Study Evaluating the Safety and Efficacy of Itacitinib in Combination with Corticosteroids for the Treatment of Steroid-Naive Acute Graft vs. Host Disease in Pediatric Subjects.” The project period is 02/12/2019 – 11/1/2020.

Noelle E. Younge (Neonatology) received an award from National Institute of Diabetes and Digestive and Kidney Diseases in the amount of $748,698 for a research project entitled “The Microbiome and Metabolism in Postnatal Growth Failure.” The project period is 06/01/2019 – 03/31/2023.

May / June 2019

Sarah C. Armstrong (Primary Care) received an award from FirstHealth of the Carolinas in the amount of $37,744 for a research study entitled Active Recreation Through Community-Healthcare Engagements (ARCHES). The project period is 07/01/2018 – 06/30/2019.

Stephen J. Balevic (Rheumatology) received an award from Childhood Arthritis & Rheumatology Research Alliance, Inc. in the amount of $90,156 for a research study entitled CARRA Registry Associate. The project period is 07/01/2019 – 06/30/2021.

Carolyn Baloh (Allergy and Immunology) received an award from Immune Deficiency Foundation in the amount of $50,000 for a research study entitled Clinical Indicators for Early Bone Loss in Common Variable Immunodeficiency. The project period is 07/01/2019 – 06/30/2020.

Ira M. Cheifetz (Critical Care Medicine) received an award from University of Pennsylvania in the amount of $14,500 for a research study entitled PROSpect - Prone and Oscillation Pediatric Clinical Trial. The project period is 06/15/2018 – 05/31/2019.

Mickey Cohen-Wolkowiez (Infectious Diseases) received an award from National Institutes of Health in the amount of $55,158 for a research study entitled A Phase 1 Randomized Single Dose Escalation Study to Evaluate the Safety, Pharmacokinetics and Immunogenicity of SAR440894 vs. Placebo in Healthy Subjects.  The project period is 6/07/2019-11/30/2019.

Michael S. Freemark (Endocrinology) received an award from Rhythm Pharmaceuticals in the amount of $482,702 for a research project entitled Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients with Rare Genetic Disorders of Obesity. The project period is 05/05/2019 – 01/31/2021.

Priya S. Kishnani (Medical Genetics) received an award from Genzyme Corporation in the amount of $361,269 for a research project entitled Immunophenotyping of Infantile Pompe Disease. The project period is 05/13/2019 – 04/30/2021.

Mohamad A. Mikati (Neurology) received an award from National Institutes of Health in the amount of $150,000 for a research study entitled AAV Mediated Gene Therapy of A Mouse Model of Alternating Hemiplegia of Childhood. The project period is May 1, 2019 – April 30, 2020.

Jennifer A. Rothman (Hematology-Oncology) received an award from Boston’s Children Hospital in the amount of $5,000 for a research study entitled Association of Platelet Parameters Identified by the Sysmex XN-1000 and Flow Cytometry with Concurrent and Subsequent Bleeding Severity in Children with Immune Thrombocytopenia (ITP). The project period is 05/21/2019 – 03/31/2021.

Muhammad S. Zafar (Neurology) received an award from LivaNova USA in the amount of $241,714 for a research study entitled Comprehensive Outcomes Registry in Subjects with Epilepsy Treated with Vagus Nerve Stimulation Therapy. The project period is 04/05/2019 – 04/30/2026.

Muhammad S. Zafar (Neurology) received an award from Eisai Inc. in the amount of $92,443 for a research study entitled An Open Label Study with an Extension Phase to Evaluate the Pharmacokinetics of Perampanel (E2007) Oral Suspension When Given as an Adjunctive Therapy in Subjects from 1 month to Less than 24 months (<2 years) of Age with Epilepsy. The project period is 05/14/2019 – 06/30/2021.

Muhammad S. Zafar (Neurology) received an award from Marinus Pharmaceuticals in the amount of $156,478 for a research project entitled A Double-blind, Randomized, Placebo-controlled Trial of Adjunctive Ganaxolone Treatment in Female Children with Protocadherin 19 (PCDH19)-related Epilepsy Followed by Long-term Open-label Treatment.” The project period is 04/08/2019 – 03/31/2022.

July 2019

Mara L. Becker (Rheumatology) received an award from Cincinnati Children’s Hospital Medical Center in the amount of $151,077 for a research study entitled “Identifying Pharmacogenomics Predictors of Methotrexate Response and Metabolite Biotransformation in JIA.” The project period is 07/15/2019 – 05/31/2020. 

Gregory E. Crawford (Medical Genetics), Priya S. Kishnani (Medical Genetics) and Timothy E. Reddy (Biomedical Engineering) received an award from National Institutes of Health in the amount of $433,137 for a research study entitled “Identifying Pathogenic Non-Coding Mutations in Rare Mendelian Disease.” The project period is 08/07/2019 – 05/31/2021. 

Christoph P. Hornik (Critical Care Medicine) received an award from Burroughs Wellcome Fund in the amount of $500,000 for a research study entitled “Real World Data to Support Pediatric Drug Labeling.” The project period is 09/01-2019 – 08/31/2024. 

Priya S. Kishnani (Medical Genetics) received an award from Sanofi Genzyme Corporation in the amount of $1,366,672 for a research study entitled “Understanding Cognitive and Neurological Pathologies in Infantile Pompe Disease.” The project period 07/03/2019 – 12/31/2021. 

Priya S. Kishnani (Medical Genetics) received an award from Sanofi Genzyme Corporation in the amount of $1,281,175 for a research study entitled “Factors in Immune Response Affecting Long-Term Treatment Outcome in Pompe Disease (CRIM).” The project period is 07/03/2019 – 12/31/2021. 

Joanne Kurtzberg (Blood and Marrow Transplantation) received an award from the National Marrow Donor Program in the amount of $1,319 for a research study entitled “Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic (CTRL-ALT-D) BMT CTN Protocol #1702.” The project period is 07/22/2019 – 07/21/2020. 

Jennifer S. Li (Cardiology) received an award from Centers for Disease Control and Prevention in the amount of $2,000,000 for a research study entitled “Surveillance of Congenital Heart Defects among Children, Adolescents, and Adults (NOFO #CDC-RFA-DD19-1902).” The project period is 09/30/2019 – 09/29/2024. 

Sallie R. Permar (Infectious Diseases) received an award from National Institutes of Health in the amount of $14,828,944 for a research study entitled “Immunologic and Virologic Determinants of Congenital Cytomegalovirus Transmission and Disease in Rhesus Monkeys.” The project period is 07/27/2019 – 06/30/2024. 

Sallie R. Permar (Infectious Diseases) received an award from National Institutes of Health in the amount of $454,003 for a research study entitled “Humoral Immune Correlates of Protection Against Congenital CMV and HSV Transmission in HIV-Infected Women.” The project period is 07/03/2019 – 06/30/2021. 

Ann M. Reed (Rheumatology) received an award from Cure JM Foundation in the amount of $69,000 for a research study entitled “Pediatrics Juvenile Myositis Program Support.” The project period is 07/01/2019 – 06/30/2020. 

Edward C. Smith (Neurology) received an award from Asklepios Biopharmaceutical, Inc. in the amount of $1,401,145 for a research study entitled “A Phase 1 Study of the Safety of AAV8-LSphGAA (ACTUS-101) in Late-Onset Pompe Disease (LOPD) Cohort II.” The project period is 07/08/2019 – 09/30/2023. 

Edward C. Smith (Neurology) received an award from Cure SMA in the amount of $60,000 for a research study entitled “SMA Care Center Registry.” The project period is 06/05/2019 – 06/04/2020. 

Edward C. Smith (Neurology) received an award from Sarepta Therapeutics in the amount of $105,393 for a research study entitled “A Long-Term Observational Study Evaluating Eteplirsen in Patients with Duchenne Muscular Dystrophy under Conditions of Routine Clinical Practice.” The project period is 06/17/2019 – 12/31/2023. 

Amelia B. Thompson (Infectious Diseases) received an award from Fred Hutchinson Cancer Research Center in the amount of $19,903 for a research project entitled “Barriers and Facilitators to Adolescent Participation in HIV Vaccine Trails.” The project period is 06/01/2019 – 11/30/2019. 

Kyle M. Walsh (Children's Health & Discovery Initiative) (Neurosurgery) received an award from National Institutes of Health in the amount of $385,193 for a research study entitled “Immune Correlates and Mechanisms of Perinatal Cytomegalovirus Infection and Later Life ALL Development.” The project period is 08/01/2019 – 07/31/2021.

August 2019

Mara L. Becker (Rheumatology) received an award from Childhood Arthritis & Rheumatology Research Alliance, Inc. in the amount of $71,361 for a research study entitled “CARRA JIA Chair Support.” The project period is 07/01/2019 – 06/30/2022.

Gregory E. Crawford (Medical Genetics) received an award from Yale University in the amount of $421,897 for a research study entitled “Chromatin Regulation during Brain Development and in ASD.” The project period is 07/01/2019 – 06/30/2023.

Mai K. ElMallah (Pulmonary and Sleep Medicine) received an award from Cystic Fibrosis Foundation in the amount of $118,941 for a research project entitled “Implementation of Outpatient Clinical Pharmacy Services: Award for a Pharmacist and/or Pharmacy Technician.” The project period is 04/01/2019 – 03/31/2022.

Mai K. ElMallah (Pulmonary and Sleep Medicine) received an award from Sarepta Therapeutics, Inc. in the amount of $130,000 for a research project entitled “Respiratory Characterization of DMD Mouse Models.” The project period is 08/21/2019 – 08/20/2020.

Genevieve G. Fouda (Infectious Diseases) received an award from Fred Hutchinson Cancer Research Center in the amount of $19,363 for a research study entitled “Antibody Responses in Pediatric Cystic Fibrosis Cohort.”  The project period is 08/01/2019 – 07/31/2020.

Priya S. Kishnani (Medical Genetics) received an award from Shire Human Genetics Therapies in the amount of $292,164 for a research study entitled “Medical Education and Awareness Program for Future Health Care Providers Treating Patients with Rare Genetic and Metabolic Diseases.” The project period is 06/25/2019 – 07/31/2021.

Laura E. Schanberg (Rheumatology) received an award from the University of Utah in the amount of $59,280 for a research study entitled ”Improving Pediatric Lupus Care and Outcomes Through The Childhood Arthritis and Rheumatology Research Alliance (CARRA) Lupus Registry.” The project period is 09/30/2019 – 09/29/2022.  

Edward C. Smith (Neurology) received an award from Biogen Inc. in the amount of $448,172 for a research study entitled “An Open-Label Extension Study for Patients with Spinal Muscular Atrophy who Previously Participated in Investigation Studies of ISIS 396443.” The project period is 08/13/2019 – 12/31/2024.

Xiaoping Zhong (Allergy and Immunology) received an award from National Institutes of Health in the amount of $402,500 for a research study entitled “Role of mTOR in Thymic Epithelial Cells in Regulating Age-Associated Thymic Involution and Function.” The project period is 09/01/2019 – 08/31/2020.

September 2019

Patricia L. Ashley (Neonatology) received an award from Infant Bacterial Therapeutics AB in the amount of $97,748 for a research study entitled “A Randomized, Double Blind, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Safety of IBP-9414 in Premature Infants 500 - 1,500 Grams Birth Weight in the Prevention of Necrotizing Enterocolitis.” The project period is 09/01/2019 – 08/31/2021.

Mara L. Becker (Rheumatology) and Daniel K. Benjamin, Jr. (Infectious Diseases) received an award from National Institutes of Health in the amount of $2,999,168 for a research study entitled “PTN2-TO#6 Clinical Pharmacokinetics and Safety Trials in Individuals with Down Syndrome.” The project period is 09/12/2019 – 09/11/2022.

Daniel K. Benjamin, Jr. (Infectious Diseases) received an award from National Institutes of Health in the amount of $840,375 for a research study entitled “Pediatric Trials Network Task Order 1 Core Function Activities Options Period 1.” The project period is 06/04/2019 – 06/03/2020.

Daniel K. Benjamin, Jr. (Infectious Diseases) and Rachel G. Greenberg (Neonatology) received an award from National Institutes of Health in the amount of $19,452,198 for a research study entitled “HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement.” The project period is 09/26/2019 – 06/30/2023.

Michael Cohen-Wolkowiez (Infectious Diseases) received an award from National Institutes of Health in the amount of $1,135,117 for a research study entitled “PTN2-TO#4 Data Closeout and Dissemination Option Period 1.” The project period is 09/14/2019 – 09/13/2020.

Mai K. ElMallah (Pulmonary and Sleep Medicine) received an award from National Institutes of Health in the amount of $1,769,467 for a research study entitled “Targeted Therapy for Pompe Disease.” The project period is 09/12/2019 – 05/31/2024.

Christoph P. Hornik (Critical Care Medicine) received an award from National Institutes of Health in the amount of $1,128,112 for a research study entitled “PTN2-TO#3 Concept Development and Clinical Trial Readiness Support Option Period 1.” The project period is 09/14/2019 – 09/13/2020.

Christoph P. Hornik (Critical Care Medicine) received an award from National Institutes of Health in the amount of $775,149 for a research study entitled “Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia.” The project period is 09/15/2019 – 08/31/2021.

Corinne M. Linardic (Hematology-Oncology) and Christopher M. Counter (Pharmacology and Cancer Biology) received an award from National Institutes of Health in the amount of $5,849,947 for a research study entitled “Defining and Targeting the Molecular Vulnerabilities of the PAX3-FOXO1 Protein in Rhabdomyosarcoma.” The project period is 09/17/2019 – 08/31/2024. 

Michael A. Moody (Infectious Diseases) received an award from National Institutes of Health in the amount of $7,929,767 for a research study entitled “Collaborative Influenza Vaccine Innovation Centers Component A: Vaccine Center.” The project period is 08/01/2019 – 07/31/2026. 

Phillip B. Smith (Neonatology) and Daniel K. Benjamin, Jr. (Infectious Diseases) received an award from National Institutes of Health in the amount of $6,750,000 for a research study entitled “ECHO Administrative Supplement – Neonatal Opioid Trials.” The project period is 09/23/2019 – 08/31/2020.

Phillip B. Smith (Neonatology) received an award from National Institutes of Health in the amount of $543,375 for a research study entitled “HEAL Consortium: Establishing Innovative Approaches for the HEALthy Brain and Child Development Study.” The project period is 09/30/2019 – 03/31/2021.

Kanecia O. Zimmerman (Critical Care Medicine) received an award from National Institutes of Health in the amount of $8,472,460 for a research study entitled “PTN2-TO#5 BPCA Innovative Trial Designs for Dosing, Safety, and Efficacy in Pediatric Therapeutics.” The project period is 09/12/2019 – 02/28/2024.

Kanecia O. Zimmerman (Critical Care Medicine) received an award from U.S. Food and Drug Administration in the amount of $4,098,917 for a research study entitled “Clinical Outcome Assessments for Pediatric Opioid-Sparing Trials.” The project period is 09/10/2019 – 08/31/2024.